Age Bias in Cancer Care for Women with Breast Cancer: How Can We Make it Better?
April 9, 2021
Following a new diagnosis of breast cancer, older women often have worse outcomes when it comes to their breast cancers and receive less than standard therapy than younger women.
Dr. Rachel Freedman, a medical oncologist at Dana-Farber Cancer Institute who specializes in breast cancer and aging, Medical Director at Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School, addresses underrepresentation in research that sets the stand for older cancer patients. She address the challenges in treating, best local therapy, and personalizing breast cancer care for older patients.